OTC Markets Group operates financial markets for 12,000 US and global securities. OTCQX is a trading platform in the US operated by the OTC Markets Group, as an alternative to listing on Nasdaq New York and NYSE. Cross-trading on OTCQX helps satisfy an increasing interest from US investors and increase accessibility to the US capital market. Companies on OTCQX meet high financial standards, follow best practice corporate governance, demonstrate compliance with US securities laws, and have a professional third-party sponsor introduction.

“We’re excited to begin trading on the OTCQX Market in the US and expand the reach beyond our Nasdaq Stockholm listing. Senzime has a strong base of international shareholders and with US being our most important commercial market, we now welcome the ability for more investors to join our leading journey towards a world free from postoperative complications”, comments Philip Siberg, CEO of Senzime.

“We are pleased to welcome Senzime to the OTCQX Best Market,” said Joe Coveney, Vice President of OTC Market Group’s Corporate Services. “Senzime will trade alongside other leading life science and medical device companies that utilize a ‘list local, trade global’ strategy to leverage their home market filings and disclosures to publicly trade in the US and expand their global investor base.”

Senzime was sponsored for OTCQX by B. Riley Securities, a qualified third-party firm responsible for providing guidance on OTCQX requirements and recommending membership.